(October 28, 2019, 12:43 PM EDT) -- BOSTON — A federal judge in Massachusetts erred in ruling that lead plaintiffs in a securities class action lawsuit against a biopharmaceutical company and certain of its executive officers failed to...
Panel Asked To Overturn District Court’s Dismissal Of Securities Law Claims
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login